This study was to optimize HPMC K4M and carbopol 934 concentration in the development of non-effervescent floating tablets (NEFTs) of glipizide as model drug using 3(2) factorial design. The time required for releasing drug of 50% and 80% and similarity factor were the target responses. HPMC K4M and carbopol 934 concentrations were the variables. The response surface methodology and optimized polynomial equations were used to select the optimal formulation with desired responses. The excipients used in tablets were compatible with glipizide as per the results of isothermal stress testing and DSC study. The drug release of entire NEFTs followed zero order kinetics and non-Fickian diffusion mechanism. Validation of the optimization technique demonstrated the reliability of the model. The optimized formulation containing 124.33 mg HPMC K4M and 25.76 mg carbopol 934 was prepared according to the software determined levels. The stability study of the optimized formulation proved the integrity of the developed formulation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carbpol.2013.11.060DOI Listing

Publication Analysis

Top Keywords

hpmc k4m
12
carbopol 934
12
non-effervescent floating
8
factorial design
8
k4m carbopol
8
optimized formulation
8
optimization hpmc
4
carbopol
4
hpmc carbopol
4
carbopol concentrations
4

Similar Publications

Article Synopsis
  • Limited solubility of miconazole nitrate (MN) is a key factor in its low effectiveness against candidiasis, prompting a study to create a microemulsion (ME) and temperature-triggered in situ gel for enhanced delivery.
  • Researchers conducted various tests, including solubility studies and the construction of pseudo-ternary phase diagrams to optimize the formulation, ultimately selecting tea tree oil, lavender oil, tween 80, and propylene glycol for the ME.
  • The resulting gel formulation (MG1) showed optimal characteristics like gelation temperature, viscosity, and a significant increase in antifungal activity compared to existing MN products, alongside no irritation in animal tests.
View Article and Find Full Text PDF

PLGA Nanoparticles Based Mucoadhesive Nasal In Situ Gel for Enhanced Brain Delivery of Topiramate.

AAPS PharmSciTech

September 2024

Department of Pharmaceutics, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, University of Mumbai, Maharashtra, India.

Oral Topiramate therapy is associated with systemic adverse effects including paresthesia,abdominal pain, and fluctuations in plasma levels. The purpose of this research was to develop an intranasal in situ gel based system comprising Topiramate polymeric nanoparticles and evaluate its potential both in vitro and in vivo. Poly (lactic-co-glycolic acid) (PLGA)nanoparticles prepared by nanoprecipitation method were added into the in situ gelling system of Poloxamer 407 and HPMC K4M.

View Article and Find Full Text PDF

Luteolin (LN), is an herbal bioactive flavone and exhibits many pharmacological activities. However, the bioavailability of LN is limited due to its inadequate solubility and significant first-pass metabolism. The present study developed transdermal LN-loaded invasomes (IVM) gel to improve the therapeutic efficacy.

View Article and Find Full Text PDF

Objective: This work is aimed to Formulate, Optimize and Evaluate Gastro-Retentive Microspheres of Antidiabetic Agent by Full Factorial Design.

Methods: Microspheres were prepared using Emulsification-cross linking technique. To this HPMC-K4M and Carbopol was dissolved in 250 ml of water and allowed to swell for 24 hr at room temperature.

View Article and Find Full Text PDF

The intranasal route has demonstrated superior systemic bioavailability due to its extensive surface area, the porous nature of the endothelial membrane, substantial blood flow, and circumvention of first-pass metabolism. In traditional medicinal practices, Bacopa monnieri, also known as Brahmi, is known for its benefits in enhancing cognitive functions and potential effects in epilepsy. This study aimed to develop and optimize a thermosensitive in-situ nasal gel for delivering Bacoside A, the principal active compound extracted from Bacopa monnieri.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!